We are live on ! Find out more
TCBP

TC BioPharm (Holdings) plc American Depositary Shares

Delisted

TCBP was delisted on the 21st of March, 2025.

3 hedge funds and large institutions have $141K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

15% less capital invested

Capital invested by funds: $166K → $141K (-$25K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$56.4K
2
VF
Virtu Financial
New York
+$56.4K

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$56.4K
2
KC
KCL Capital
New York
-$37K
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
1
Legal & General Group
United Kingdom
$58K
Renaissance Technologies
2
Renaissance Technologies
New York
$41K +$56.4K +1 New
VF
3
Virtu Financial
New York
$35K +$56.4K +1 New
WAM
4
Warberg Asset Management
Illinois
$4K -$56.4K -1 Closed
MFGM
5
Marshall Financial Group (Maryland)
Maryland
$3K
KC
6
KCL Capital
New York
-$37K -1 Closed

TCBP Hedge Fund Activity: Q3 2022 in Review

3 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2022, worth a combined $141K — down 15% from $166K a quarter earlier.

Fund positioning in TCBP was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $56.4K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $56.4K sold.

  • 3 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $141K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2022, down 15% quarter-over-quarter.
  • 2 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2022 and 2 closed out, a net change of 0 holders.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q3 2022 was Renaissance Technologies, an estimated $56.4K added.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2022 was Warberg Asset Management, an estimated $56.4K sold.

Based on aggregated 13F filings for Q3 2022.